Stammdaten
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
Unternehmen & Branche
| Name | bioAffinity Technologies, Inc. |
|---|---|
| Ticker | BIAF |
| CIK | 0001712762 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Diagnostics & Research |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 12,1 Mio. USD |
| Beta | -0,82 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 6,161,959 | -14,909,754 | -8.66 | 10,960,772 | 7,277,656 |
| 2025-09-30 | 10-Q | 1,446,066 | -5,051,084 | -4.74 | 11,546,369 | 8,902,198 |
| 2025-06-30 | 10-Q | 1,269,483 | -4,060,787 | -0.17 | 4,751,075 | -2,136,108 |
| 2025-03-31 | 10-Q | 1,853,597 | -2,660,417 | -0.16 | 5,547,283 | 1,439,404 |
| 2024-12-31 | 10-K | 9,362,022 | -9,039,831 | -22.50 | 6,513,667 | 2,602,036 |
| 2024-09-30 | 10-Q | 2,350,386 | -2,000,840 | -4.84 | 6,552,014 | 3,121,025 |
| 2024-06-30 | 10-Q | 2,397,652 | -2,110,279 | -0.19 | 6,656,448 | 3,433,114 |
| 2024-03-31 | 10-Q | 2,406,391 | -1,961,815 | -0.20 | 8,049,266 | 5,257,051 |
| 2023-12-31 | 10-K | 7,900,000 | -7,937,011 | -0.91 | 8,221,552 | 4,855,255 |
| 2023-09-30 | 10-Q | 300,236 | -2,290,884 | -0.26 | 10,189,464 | 6,993,909 |
| 2023-06-30 | 10-Q | 3,631,208 | -1,740,173 | -0.20 | 8,873,499 | 8,098,348 |
| 2023-03-31 | 10-Q | 1,806,196 | -1,532,790 | -0.18 | 10,464,569 | 9,668,266 |
| 2022-12-31 | 10-K | 6,900,000 | -8,154,113 | -1.81 | 12,182,125 | 11,043,443 |
| 2022-09-30 | 10-Q | 1,150 | -4,919,458 | -1.17 | 14,062,687 | 12,598,500 |
| 2022-06-30 | 10-Q | 1,306 | -88,052 | -0.03 | -16,786,329 | |
| 2022-03-31 | 10-Q | -1,472,020 | -16,724,777 | |||
| 2021-12-31 | 10-K | -6,326,413 | 1,453,308 | -15,790,719 | ||
| 2021-09-30 | 10-Q | -1,513,794 | -15,689,857 | |||
| 2021-06-30 | 10-Q | 764,269 | -14,155,757 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.